Philips Sleep Apnea Machine Safety Fears Grow; Shares Slump
Royal Philips NV slumped after the Food and Drug Administration warned about a new safety issue involving the
2023-11-29 17:16
Sanofi’s Dupixent Shows Strong Efficacy in Second Lung Trial
Sanofi’s prescription drug Dupixent showed additional promise in helping patients with a chronic lung disorder breathe better and
2023-11-27 14:55
FDA Weighing What to Do About $900,000 Drug That May Not Work
The cancer drug Folotyn, one of the most expensive in the US, received a short-cut approval from US
2023-11-16 18:57
An Opioid-Like Drink Is Masquerading As a Wholesome Alcohol Alternative
When Krista Marquick discovered kratom, it filled a hole in her life that quitting alcohol had left —
2023-11-10 18:56
New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper
An effective and massively popular weight-loss drug has made Novo Nordisk A/S billions of dollars and turned it
2023-11-09 07:20
Sarepta Seeks Broader Approval for Gene Therapy Even After Drug Trial Fizzled
Normally when a drug fails to show a clear effect in a final-stage trial, the company developing it
2023-11-01 07:15
Gene Therapy for Kids’ Deadly Muscle Disease Fails to Reach Trial Goal
Roche Holding AG shares dropped after a trial of its gene therapy for Duchenne muscular dystrophy did not
2023-10-31 16:57
China’s Junshi Nabs FDA Approval in Rare Success for US Foray
The US Food and Drug Administration has cleared the first China-developed cancer drug similar to Merck & Co.’s
2023-10-28 11:20
Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol-Myers Squibb Co. has agreed to buy cancer drugmaker Mirati Therapeutics Inc. for $4.8 billion as the company
2023-10-09 09:23
Abortion Pill Access Preserved by US Appeals Court, With Limits
A US appeals court on Wednesday ruled that access to the abortion pill should be preserved with some
2023-08-17 04:52
Sage Tumbles as Depression Pill Approval Omits Major Disorder
Sage Therapeutics Inc. slumped in early trading after regulators granted approval to its fast-acting pill only for postpartum
2023-08-07 20:23
Astellas Pharma Secures US FDA Approval for Izervay
The US Food and Drug Administration approved Astellas Pharma Inc.’s Izervay for the treatment of age-related macular degeneration,
2023-08-05 10:29